GENSIGHT BIOLOGICS SA (SIGHT.PA) Stock Analyst Ratings

Europe • Euronext Paris • EPA:SIGHT • FR0013183985

0.085 EUR
+0.01 (+6.92%)
Last: Feb 6, 2026, 05:29 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to SIGHT.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 0.44. This target is 416% above the current price.
  • SIGHT.PA was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SIGHT.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • SIGHT.PA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
SIGHT.PA Historical Analyst RatingsSIGHT.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.090.400.440.440.48 - 375.29% 416.00% 416.00% 468.24%

Related screens

Find peers 30% below price target
SIGHT.PA Current Analyst RatingSIGHT.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades

GENSIGHT BIOLOGICS SA / SIGHT.PA FAQ

Can you provide the average price target for GENSIGHT BIOLOGICS SA stock?

11 analysts have analysed SIGHT.PA and the average price target is 0.44 EUR. This implies a price increase of 416% is expected in the next year compared to the current price of 0.085.


What is the consensus rating for GENSIGHT BIOLOGICS SA (SIGHT.PA) stock?

The consensus rating for GENSIGHT BIOLOGICS SA (SIGHT.PA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.